Search Results - "Schothorst, K.L.C"

Weekly paclitaxel as first-line chemotherapy for elderly patients with metastatic breast cancer. A multicentre phase II trial by ten Tije, A.J, Smorenburg, C.H, Seynaeve, C, Sparreboom, A, Schothorst, K.L.C, Kerkhofs, L.G.M, van Reisen, L.G.P.M, Stoter, G, Bontenbal, M, Verweij, J

“…Paclitaxel is a cytotoxic agent with proven antitumour activity in metastatic breast cancer. Weekly administration of paclitaxel has demonstrated sustained…”
Get full text

671 Phase III study comparing AT (Adriamycin, Docetaxel) to FAC (Fluorouracil, Adriamycin, Cyclophosphamide) as first-line chemotherapy (CT) in patients with metastatic breast cancer (MBC) by Bontenbal, M., Braun, J.J., Creemers, G.J., de Boer, A.C., Janssen, J.Th.P., Leys, M.B.L., Schothorst, K.L.C., Schmitz, P.I.M., Bokma, J.J., Seynaeve, C.

Get full text